Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 4005 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 4170 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 4575 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 4741 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 4800 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 6133 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 8092 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 111120 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 115500 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 131611 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 140054 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 156104 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 159533 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 175759 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 195402 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 196992 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 198552 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 198839 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 207532 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 210399 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 214594 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 222822 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 224186 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 232395 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 242561 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 244802 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 251155 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 253649 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 254322 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 259497 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 262814 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 265799 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 267036 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 268265 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 272765 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 276538 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 282889 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 284211 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 286323 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 288186 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 291701 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 299073 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 302430 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 308616 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 309001 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 315704 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 324313 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 327817 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 329381 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 333895 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 337434 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 346917 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 348282 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 351362 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 352408 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 353444 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 366304 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 374659 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 376172 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 380159 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 383397 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 384482 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 387856 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 388707 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 389953 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 391365 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 397666 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 403537 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 405356 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 416900 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 419611 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 425675 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 446657 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 458775 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 464921 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 475235 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 480580 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 489368 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 492898 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 499562 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 501902 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 532647 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 534978 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 538018 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 545676 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 550300 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 564470 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 582190 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 588925 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 588980 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 592427 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 593482 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 595402 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 602615 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 610804 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 636058 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 664767 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 726538 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 768573 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+H)+ | 905778 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 11984 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 15219 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 19588 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 20465 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 20586 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 20963 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 21488 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 21902 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 22434 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 22669 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 23745 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 24077 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 24652 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 24828 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 26943 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 28764 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 29594 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 29702 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 29751 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 29875 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 30169 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 30860 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 31092 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 32509 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 32793 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 33408 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 33600 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 34000 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 34728 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 34894 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 36604 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 37010 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 37117 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 37496 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 39338 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 40486 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 40940 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 41421 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 43237 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 43784 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 44527 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 45815 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 47240 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 48272 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 48890 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 49065 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 51121 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 52277 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 52552 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 53863 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 55108 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 58674 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 58983 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 59463 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 63202 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 64433 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 64540 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 64760 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 69692 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 76602 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 79362 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 80841 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 81312 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 81974 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 86135 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 88725 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 88883 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 92812 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 94141 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 112089 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 112331 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 116228 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 117524 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 145133 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 147112 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 161321 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 170955 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 175634 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 182294 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 208855 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 210217 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 221034 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 240758 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 264142 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 270831 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 276195 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | 283565 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | PROLINE (CAS# 147-85-3); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |